Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation

OneConnect upgrades IPO to $347m
Ping An's financial technology spinoff, which also counts SoftBank Vision Fund and SBI as shareholders, has sold an additional $35.2m in shares in the offering.
Zelgen sells Shanghai on $294m IPO
Minsheng Life-backed oncology drug developer Zelgen has priced an initial public offering set to value it at more than $1.1bn.
OneConnect wins $312m in IPO
Ping An’s fintech spinoff, OneConnect, has floated in the US having raised $750m from investors including SoftBank Vision Fund and SBI last year.
EHang lands on public markets in $40m IPO
Autonomous drone developer EHang floated at the bottom of its range in an initial public offering that allowed Lung Biotechnology and United Therapeutics to exit.
Bill.com fills up with $216m IPO
Financial automation software producer Bill is floating above its range as Fleetcor, Mastercard, Amex and a host of banks all scored exits.
Analysis: IPOs of corporate-backed businesses possibly cooling down
The number of flotations of companies that have previously received corporate backing has been growing over the past years but by the end of 2019 they may register a slight slowdown.
36Kr broadcasts $20m IPO
Ant Financial and Nikkei-backed 36Kr has raised just a fifth of its original IPO target and shares took another 10% hit on the first day of trading.
Rapt wraps up $36m initial public offering
The Celgene and GV-backed small molecule drug developer floated at the bottom of its range, raising less than half the target it set last week.

Other News

Phathom fattens up IPO to $209m
The Takeda-backed gastrointestinal disease therapy developer has boosted its initial public offering to $209m after its shares rose 23% post-flotation.
Phathom forces its way into public markets
Gastrointestinal disease drug developer Phathom raised almost $182m in an initial public offering that involved Takeda bumping up its equity stake in the company.
Progyny begets $130m IPO
GSK and Merck Group-backed Progyny floated in an offering that involved the fertility benefits manager pricing its shares below their range.
Vir Bio rides to $143m in IPO
SoftBank Vision Fund-backed immunology therapy developer Vir will float at the bottom of its range, having raised in excess of $820m in VC funding in roughly three years.
BioNTech binds itself to public markets
The Eli Lilly, Pfizer and Sanofi-backed cancer therapy developer raised $150m despite reducing the number of shares in the IPO and floating beneath its range.
Aprea closes $97.8m IPO
The underwriters for Praktikertjänst-backed Aprea Therapeutics have taken up the over-allotment option in full to boost proceeds to nearly $97.8m.

Editor's Picks

Bill.com fills up with $216m IPO
Financial automation software producer Bill is floating above its range as Fleetcor, Mastercard, Amex and a host of banks all scored exits.
Peloton pulls itself to billion-dollar IPO
Comcast NBCUniversal and Grace Beauty scored exits as Peloton Interactive floated at the top of its range to raise $1.16bn, getting a further $100m in a private placement.
Cloudflare clocks up $525m in IPO
Alphabet, Baidu, Microsoft and Qualcomm all notched up exits as the cloud services provider floated above a range that had already been increased.
BridgeBio crosses over to public markets with $349m
AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.
test reg

Login